Vertex Pharmaceuticals Incorporated shares owned by Nissay Asset Management Corp
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Nissay Asset Management Corp
from 13F filings
Historical chart of Nissay Asset Management Corp investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Nissay Asset Management Corp consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Nissay Asset Management Corp
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $26M | 67k | 391.64 |
| 2025-06-30 | $29M | 66k | 445.20 |
| 2025-03-31 | $31M | 64k | 484.82 |
| 2024-12-31 | $24M | 58k | 408.76 |
| 2024-09-30 | $26M | 55k | 465.08 |
| 2024-06-30 | $24M | 51k | 468.72 |
| 2024-03-31 | $19M | 46k | 418.01 |
| 2023-09-30 | $11M | 33k | 347.74 |
| 2023-06-30 | $11M | 31k | 351.91 |
| 2023-03-31 | $9.7M | 31k | 315.07 |
| 2022-12-31 | $9.1M | 32k | 288.78 |
| 2022-09-30 | $9.5M | 33k | 289.54 |
| 2022-06-30 | $9.0M | 32k | 281.80 |
| 2022-03-31 | $7.5M | 29k | 260.97 |
| 2021-12-31 | $6.3M | 29k | 219.61 |
| 2021-09-30 | $5.0M | 28k | 181.38 |
| 2021-06-30 | $5.3M | 27k | 201.63 |
| 2021-03-31 | $5.4M | 25k | 214.90 |
| 2020-12-31 | $6.0M | 26k | 236.32 |
| 2020-09-30 | $7.3M | 27k | 272.13 |
| 2020-06-30 | $9.2M | 32k | 290.31 |
| 2020-03-31 | $7.1M | 30k | 237.95 |
| 2019-12-31 | $6.3M | 29k | 218.97 |
| 2019-09-30 | $5.1M | 30k | 169.40 |
| 2019-06-30 | $5.2M | 28k | 183.37 |
| 2019-03-31 | $5.4M | 29k | 183.94 |
| 2018-12-31 | $5.0M | 30k | 165.70 |
| 2018-09-30 | $5.7M | 30k | 192.75 |
| 2018-06-30 | $4.9M | 29k | 169.95 |
| 2018-03-31 | $4.9M | 30k | 162.98 |
| 2017-12-31 | $4.7M | 31k | 149.81 |
More positions owned by Nissay Asset Management Corp
View all positions for Nissay Asset Management Corp
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated